Apr 25 |
Standard Biotools announces operational restructuring plan including headcount reduction
|
Apr 25 |
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
|
Apr 25 |
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
|
Apr 16 |
Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic?
|
Apr 8 |
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
|
Apr 3 |
Standard Biotools enters strategic engagement with Bristol Myers for expanded use of Somascan platform
|
Apr 3 |
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
|
Apr 2 |
Is Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)?
|
Mar 19 |
Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)
|
Mar 18 |
Standard BioTools exchanges all outstanding Series B convertible preferred stock for common stock
|